ArticleBMC ophthalmology2026
Factors influencing the success of patch therapy in patients with intermittent exotropia: a retrospective case-control study.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPart-time occlusion is used to delay or avoid surgery in intermittent exotropia; however, the treatment criteria and optimal duration remain unclear. This retrospective case-control study aimed to identify factors influencing deviation angle normalization and recurrence risk after patch therapy in intermittent exotropia.
methodsPatients with intermittent exotropia who underwent 2–4-hours patching were divided into treatment success and failure groups; the treatment success group was divided into recurring and non-recurring subgroups. Patients whose deviation angle recovered to 10 prism diopters (PD) or under were seen as treatment success, patients whose deviation angle went 15 PD or more in the 1 year follow up after treatment success was achieved were seen as recurring group. Visual acuity, refraction, deviation angle, control, stereoacuity, patching time, and duration were investigated. The main outcomes included characteristics of patients whose deviation angle normalized. The independent t-test and chi-square test were used to compare continuous and categorical variables, respectively. Shapiro-Wilk normality testing was conducted before analyses. Cox regression analysis was used to compare the treatment success and treatment failure groups. Logistic regression analysis was used to compare the recurring and non-recurring subgroups within the treatment success group. Kaplan–Meier survival analysis was performed to calculate the probability of treatment success, and the log-rank test was used to compare the patching duration between the treatment failure and success groups.
resultsAmong the 59 patients included, 30 required surgeries due to treatment failure. Eleven of 29 patients in the treatment success group experienced recurrence. The deviation angle normalized within an average of 494 days in successfully treated patients; it normalized within 331 days in 50% of them. The treatment failure group had a larger initial deviation angle (p ≤ .0001). Shorter patching duration was a predictive factor for treatment success (p = .002). However, no significant factors were found between recurring and non-recurring cases.
conclusionsPatch duration and good compliance, especially considering age, are key factors in treatment success.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.